| 967 |
Cardiac Resynchronization Therapy Induces Major Structural and Functional Reverse Remodeling In Mild Heart Failure. 24 month results of the REVERSE trial. |
|
Sep. 29. 09 |
| 966 |
Characteristics of patients enrolled in the Predictors of Response to CRT (PROSPECT) trial: comparison of subgroups according to extent of LV reverse remodeling. |
|
Sep. 29. 09 |
| 965 |
Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial. |
|
Sep. 29. 09 |
| 964 |
The impact of achieved heart rate and reduction in heart rate on cardiovascular outcomes: an analysis of the Ivabradine arm of the BEAUTIFUL trial. |
|
Sep. 29. 09 |
| 963 |
B-CONVINCED: Beta-blocker CONtinuation Versus INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. |
|
Sep. 29. 09 |
| 962 |
Reduction in the risk of heart failure with preventive cardiac resynchronization therapy: MADIT-CRT Trial. |
|
Sep. 29. 09 |
| 961 |
A randomized evaluation of irbesartan versus placebo in patients with Atrial Fibrillation (factorial design of ACTIVE Program). |
|
Sep. 29. 09 |
| 960 |
Effects of Rolofylline in Patients with Acute Heart Failure Syndrome and Renal Impairment: Findings from the PROTECT Study. |
|
Sep. 29. 09 |
| 959 |
Effects of Valsartan on morbidity and mortality in uncontrolled hypertensive patients with high risk of cardiovascular events (KYOTO Heart Study). |
|
Sep. 29. 09 |
| 958 |
Randomized trial of 3-limus agent-eluting stents with biodegradable or permanent polymer coating: ISAR-TEST-4 study. |
|
Sep. 29. 09 |
